Clinical Supply, Pharmacy and Regulation - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Supply

Pharmacy

Regulation

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

The Pharma Data

JANUARY 24, 2021

In clinical research, Cepharanthine exhibits multiple pharmacological properties including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases.

Drugs

Drugs Containment Development Sales

A supply chain to match the changing face of science

Drug Discovery World

NOVEMBER 3, 2022

At this stage, there needs to be consideration of how the therapy can be managed through different languages both in terms of product labelling and system requirements and how to facilitate accurate scheduling across different time zones and regulations. 15 years later . References .

Gene Therapy

Gene Therapy Production Development Business Development

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

A supply chain to match the changing face of science

Stay Connected